July 14, 2021 02:32 PM EDT
Pharma
FDA+

FDA chides Am­gen over mis­lead­ing ban­ner ad for Neu­las­ta

Zachary Brennan

Senior Editor

In its sec­ond un­ti­tled let­ter of 2021, the FDA’s Of­fice of Pre­scrip­tion Drug Pro­mo­tion raised ques­tions about Am­gen’s mis­lead­ing ban­ner ads …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times